4//SEC Filing
MOCH KENNETH I 4
Accession 0001192482-21-000642
CIK 0001621443other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:21 PM ET
Size
6.9 KB
Accession
0001192482-21-000642
Insider Transaction Report
Form 4
MOCH KENNETH I
Director
Transactions
- Award
Common Stock
2021-08-03+5,000→ 5,000 total - Award
Stock Option (right to buy)
2021-08-03+7,500→ 7,500 totalExercise: $4.44Exp: 2031-08-03→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The restricted stock award vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders.
- [F2]The option vests in full upon the earlier of (i) August 3, 2022, or (ii) the day before the Company's 2022 annual meeting of stockholders.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001070009
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 5:21 PM ET
- Size
- 6.9 KB